Advanced Search
LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314
Citation: LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314

Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus

More Information
  • The aim of study was to determine the relationship between the biomarker of glucose and lipid metabolism and NG, NG′-asymmetric dimethylarginine(ADMA), total homocysteine(tHcy), adiponectin(APN)and pentraxin 3(PTX3)in type 2 diabetes mellitus rats. Diabetes was induced in Sprague-Dawley rats by a single intraperitoneal injection of 35mg/kg streptozotocin(STZ). Before and 2nd, 4th, 7th, 9th weeks after STZ injection, fasting plasma glucose(FPG), fasting insulin(FINS), OGTT, serum lipid(TC, TG and LDL-C), ADMA, tHcy, APN, PTX3 were determined. Compared with the groups of control and high fat diet(HFD), FPG, Homeostasis model assessment for insulin resistence index(HOMA-IR), TC, TG and LDL-C level of type 2 diabetes mellitus(T2DM)groups were significantly increased. In T2DM group, the concentration of ADMA increased gradually, tHcy decreased by degrees, APN reduced significantly, the PTX3 elevated remarkably. Our results indicate that ADMA, tHcy, APN, PTX3 are well correlated with glucose and lipid metabolism biomarkers. The plurality of biomarkers mentioned before should be monitored to evaluate the cardiovascular risk of type 2 diabetes mellitus.
  • Related Articles

    [1]LI Yufei, CHU Haiping, LI Yan, WANG Xiaojing, MU Yanling, SUN Jie. Mechanism of 3-arylcoumarin derivatives inhibiting vascular calcification[J]. Journal of China Pharmaceutical University, 2022, 53(2): 222-231. DOI: 10.11665/j.issn.1000-5048.20220213
    [2]ZHAO Xiaomei, WANG Xin, JI Xia, ZHANG Hua, ZHANG Pingping, HU Guoqiang. Synthesis and antitumor activities of 1, 2-benzothiazines[1, 3, 4]thiadiazolo[3, 2-a][1, 3, 5]triazin derivatives[J]. Journal of China Pharmaceutical University, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
    [3]XU Meng, GE Zhixin, HAO Meixi, ZHANG Can. Synthesis and in vitro biological activity of 3-phenyl-3-pyrrolylpentane derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(1): 30-37. DOI: 10.11665/j.issn.1000-5048.20160104
    [4]Preparation and Bioactivity of Cationic Porphyrins Bearing Mixed 3-quinolyl and 3-pyridyl Meso Groups[J]. Journal of China Pharmaceutical University, 2003, (2): 13-19.
    [5]Improved Synthesis of 2-(3-benzoylphenyl) propionitrile[J]. Journal of China Pharmaceutical University, 2001, (3): 27-28.
    [6]Synthesis of 3-Substituted-1, 2, 3, 9-tetrahydro-4H-carbazol-4-one Derivatives[J]. Journal of China Pharmaceutical University, 1998, (6): 403-407.
    [7]Synthesis and Anesthetic Activity of 3-Methyl Fentanyl Derivatives[J]. Journal of China Pharmaceutical University, 1993, (5): 257-263.
    [8]Synthesis of 7-Amino-3-Vinyl-3-Cephem-4-Carboxylic Acid[J]. Journal of China Pharmaceutical University, 1993, (4): 246-247.
    [9]Synthesis and Biological Activity of 3-Aminopropiophenone and 1-Phenyl-3-Aminopropanol Compounds[J]. Journal of China Pharmaceutical University, 1992, (3): 129-134.
    [10]Zhou Huishu, Huang Cifu, Duan Tinghan. Synthesis of 3-Bromomethylcephem Sulphoxide[J]. Journal of China Pharmaceutical University, 1981, (1): 61-62.
  • Cited by

    Periodical cited type(2)

    1. 徐杨,周伟俊,郑伟然,杨键,王艺欣,刘涛. 中成药中药物和药用辅料“质控对称”(QC-Symmetry)的探讨. 中草药. 2025(04): 1385-1393 .
    2. 李琪琪,张光琼,李玲燕,贺智勇,陈英,王玉娥,吴兴杰,沈祥春,陶玲. 肉豆蔻酸异丙酯自乳化递送系统的构建及其蛋白晕形成能力. 药物评价研究. 2025(06): 1517-1528 .

    Other cited types(0)

Catalog

    Article views (1088) PDF downloads (1821) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return